Compounds > 1,2-distearoyllecithin
Page last updated: 2024-08-24

1,2-distearoyllecithin and Leukemia L 1210

1,2-distearoyllecithin has been researched along with Leukemia L 1210 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bally, MB; Boman, NL; Cullis, PR; Mayer, LD; Nayar, R; Thies, RL1

Other Studies

1 other study(ies) available for 1,2-distearoyllecithin and Leukemia L 1210

ArticleYear
Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia.
    Cancer chemotherapy and pharmacology, 1993, Volume: 33, Issue:1

    Topics: Animals; Cholesterol; Drug Carriers; Leukemia L1210; Liposomes; Mice; Mice, Inbred DBA; Neoplasm Transplantation; Phosphatidylcholines; Survival Rate; Vincristine

1993